<DOC>
	<DOCNO>NCT01764347</DOCNO>
	<brief_summary>This pilot clinical trial study magnetic resonance imaging ( MRI ) -transrectal ultrasound ( TRUS ) fusion image-guided prostate biopsy follow radical prostatectomy patient prostate cancer . Diagnostic procedure , MRI-TRUS fusion image-guided prostate biopsy may help find diagnose prostate cancer</brief_summary>
	<brief_title>Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy Patients With Prostate Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate accuracy new image-guided target needle biopsy use ex-vivo human prostate obtain fresh radical prostatectomy specimen . OUTLINE : Patients undergo robotic radical prostatectomy , follow 3 MRI-TRUS fusion image-guided prostate biopsy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Subjects must biopsyproven prostate cancer , prostatespecific antigen ( PSA ) &gt; = 4 ng/ml abnormal digital rectal examination ( DRE ) consent prostate biopsy Subjects must least 2 , preferably 3 , preoperative magnetic resonance imaging ( MRI ) identify malignant benign lesion measure 10 mm 15 mm diameter within prostate Subjects must decide prostate surgically remove Patients give informed consent Patients extracapsular extension prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>